Trial intelligence / Profile preview

Pioglitazone + Pegasys + Copegus in HCV Genotype 1

NCT00545233Phase 4Completed

Sponsor
Roche
Start
Jan 2008
Primary completion
Dec 2010
Modality
Small Molecules
Countries
2
01

Overview

A Phase 4 trial of pioglitazone in hepatitis C (HCV), sponsored by Roche. Started Jan 2008; status: completed.

02

Drugs

pioglitazone
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT00545233.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00545233.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call